Legal Representation
Attorney
Andrew P. Cernota
USPTO Deadlines
Next Deadline
2038 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 2001-02-27)
Due Date
February 27, 2031
Grace Period Ends
August 27, 2031
Application History
22 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Nov 5, 2021 | CAEX | O | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | Loading... |
Feb 27, 2020 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | Loading... |
Mar 31, 2010 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | Loading... |
Mar 31, 2010 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | Loading... |
Mar 30, 2010 | E89R | I | TEAS SECTION 8 & 9 RECEIVED | Loading... |
May 15, 2007 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
Feb 21, 2007 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
Nov 28, 2006 | CFIT | O | CASE FILE IN TICRS | Loading... |
Oct 25, 2006 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
Mar 25, 2005 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Feb 27, 2001 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Dec 5, 2000 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Nov 3, 2000 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
Oct 3, 2000 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Aug 16, 2000 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jul 17, 2000 | CNFR | O | FINAL REFUSAL MAILED | Loading... |
Jul 14, 2000 | IUAA | P | USE AMENDMENT ACCEPTED | Loading... |
Jun 2, 2000 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Dec 20, 1999 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
Nov 2, 1999 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jul 13, 1999 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
Jul 1, 1999 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"ACCESS"